Drug manufacturers must submit reports on quality problems to FDA. Almost half of sites still don't, new report finds
The FDA’s postmarket regulations require that drug manufacturers notify the agency about any significant product quality defects in marketed products within three working days. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
